Invenomic Capital Management’s Orion OEC Stock Holding History

Invenomic Capital Management’s Portfolio OEC Stock Details OEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-642,789	Closed	-$3.39M	–	173
2025 Q4	$3.39M	Buy	642,789 +7,631	+1%	+$41.4K	0.16%	124
2025 Q3	$4.81M	Buy	635,158 +85,800	+16%	+$867K	0.23%	104
2025 Q2	$5.76M	Buy	549,358 +307,651	+127%	+$3.48M	0.33%	93
2025 Q1	$3.13M	Buy	+241,707	New	+$3.42M	0.16%	137
2023 Q1	–	Sell	-574,062	Closed	-$10.2M	–	169
2022 Q4	$10.2M	Sell	574,062 -143,732	-20%	-$2.42M	0.69%	51
2022 Q3	$9.58M	Sell	717,794 -20,350	-3%	-$331K	0.82%	43
2022 Q2	$11.5M	Buy	738,144 +187,927	+34%	+$3.15M	0.81%	40
2022 Q1	$7.25M	Buy	+550,217	New	+$9.48M	0.77%	39
2021 Q1	–	Sell	-29,063	Closed	-$498K	–	145
2020 Q4	$498K	Sell	29,063 -118,815	-80%	-$1.81M	0.13%	96
2020 Q3	$1.85M	Sell	147,878 -45,662	-24%	-$547K	1.02%	33
2020 Q2	$2.05M	Buy	193,540 +33,710	+21%	+$311K	1.52%	17
2020 Q1	$1.19M	Sell	159,830 -91,182	-36%	-$1.32M	0.97%	37
2019 Q4	$4.84M	Buy	+251,012	New	+$4.54M	1.94%	11

Other funds holding OEC

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Divisar Capital Management San Francisco, California $434M AUM 170.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invenomic Capital Management's OEC Position: Q1 2026 in Review

Invenomic Capital Management sold out of Orion (OEC) in Q1 2026, closing a stake of 642,789 shares — an estimated $3.39M sold.

Invenomic Capital Management first reported a position in OEC in Q4 2019 and held it in 13 quarters. The position peaked at $11.5M in Q2 2022. 181 funds tracked by Wall St. Rank hold OEC as of Q1 2026.

Invenomic Capital Management reported no remaining Orion position as of Q1 2026 after selling out during the quarter.
Invenomic Capital Management sold 642,789 Orion shares in Q1 2026, an estimated $3.39M.
Invenomic Capital Management first reported a position in Orion in Q4 2019 and held it in 13 quarters.
Invenomic Capital Management's Orion position peaked at $11.5M in Q2 2022.
181 funds tracked by Wall St. Rank held Orion as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.